Similar articles

• Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.

  Baker BR, Lourens GJ. Baker BR, et al. J Med Chem. 1968 Jan;11(1):26-33. doi: 10.1021/jm00307a005. J Med Chem. 1968. PMID: 5237171 No abstract available.
• Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.

  Baker BR, Lourens GJ. Baker BR, et al. J Med Chem. 1968 Jan;11(1):38-41. doi: 10.1021/jm00307a007. J Med Chem. 1968. PMID: 5237173 No abstract available.
• Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity.

  Baker BR, Lourens GJ. Baker BR, et al. J Med Chem. 1969 Jan;12(1):92-4. doi: 10.1021/jm00301a024. J Med Chem. 1969. PMID: 5763049 No abstract available.
• Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.

  Baker BR, Lourens GJ. Baker BR, et al. J Med Chem. 1969 Jan;12(1):101-4. doi: 10.1021/jm00301a026. J Med Chem. 1969. PMID: 5763002 No abstract available.
• Active-site directed irreversible inhibitors of dihydrofolate reductase.

  Baker BR. Baker BR. Ann N Y Acad Sci. 1971 Nov 30;186:214-26. doi: 10.1111/j.1749-6632.1971.tb31146.x. Ann N Y Acad Sci. 1971. PMID: 4943574 Review. No abstract available.